Multidrug resistance protein 1 (MRP1) in rabbit conjunctival epithelial cells: Its effect on drug efflux and its regulation by adenoviral infection

Pharmaceutical Research

Volumn 24, Issue 8, 2007, Pages 1490-1500

  Yang, Johnny J ^a,c   Ann, David K ^a   Kannan, Ram ^b   Lee, Vincent H L ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Adenoviral infection; Conjunctival epithelial cell; Cytokine; MRP1; Regulation

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANION; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CROMOGLYCATE DISODIUM; CYTOKINE; DICLOFENAC; FLUORESCEIN; FLURBIPROFEN; GLUTATHIONE; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 6; LEUKOTRIENE C4; MONOCLONAL ANTIBODY; MULTIDRUG RESISTANCE PROTEIN 1; OFLOXACIN; PREDNISOLONE; PROBENECID; TUMOR NECROSIS FACTOR ALPHA; URICOSURIC AGENT;

ADENOVIRUS 5; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL ISOLATION; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; ENZYME SUBSTRATE; EPITHELIUM CELL; FILTER; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS INFECTION; WESTERN BLOTTING;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASE SEQUENCE; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; BUTHIONINE SULFOXIMINE; CACO-2 CELLS; CELLS, CULTURED; CONJUNCTIVA; CYTOKINES; EPITHELIAL CELLS; FLUORESCEIN; GENE EXPRESSION; HUMANS; INDOMETHACIN; LEUKOTRIENE C4; MOLECULAR SEQUENCE DATA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHARMACEUTICAL PREPARATIONS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 34250824087     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9267-7     Document Type: Article

References (44)

1. W. T. Bellamy. P-glycoprotein and multidrug resistance. Annu. Rev. Pharmacol. Toxicol. 36:161-183 (1996).
2. S. P. C. Cole and R. G. Deeley. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. BioEssays 20:934-940 (1998).
3. P. W. Wigler. Cellular drug efflux and reversal therapy of cancer. J. Bioenerg. Biomembranes 28:279-284 (1996).
4. F. Thiebaut, T. Tsuruo, H. Hamada, M. M. Gottesman, I. Pastan, and M. C. Willingham. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U. S. A. 84:7735-7738 (1987).
5. M. J. Flens, G. J. Zaman, P. van der Valk, M. A. Izquierdo, A. B. Schroeijers, G. L. Scheffer, P. van der Groep, M. de Haas, C. J. Meijer, and R. J. Scheper. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1237-1247 (1996).
6. J. A. Holash and P. A. Stewart. The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers. Brain Res. 629:218-224 (1993).
7. K. Kawazu, K. Yamada, M. Nakamura, and A. Ota. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. Invest. Ophthalmol. Vis. Sci. 40:1738-1744 (1999).
8. P. Saha, J. J. Yang, and V. H. L. Lee. Existence of a P-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest. Ophthalmol. Vis. Sci. 39:1221-1226 (1998).
9. R. Evers, G. J. Zaman, L. van Deemter, H. Jansen, J. Calafat, L. C. Oomen, R. P. Oude Elferink, P. Borst, and A. H. Schinkel. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. J. Clin. Invest. 97:1211-1218 (1996).
10. P. Borst, R. Evers, M. Kool, and J. Wijnholds. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:1295-1302 (2000).
11. H. Roelofsen, G. J. Hooiveld, H. Koning, R. Havinga, P. L. Jansen, and M. Muller. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. J. Cell Sci. 112(Pt 9):1395-1404 (1999).
12. Y. Zhang, J. D. Schuetz, W. F. Elmquist, and D. W. Miller. Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J. Pharmacol. Exp. Ther. 311:449-455 (2004).
13. R. B. Wang, C. L. Kuo, L. L. Lien, and E. J. Lien. Structure-activity relationship: analyses of P-glycoprotein substrates and inhibitors. J. Clin. Pharm. Ther. 28:203-228 (2003).
14. R. G. Deeley and S. P. Cole. Substrate recognition and transport by multidrug resistance protein 1 (ABCC1). FEBS Lett. 580:1103-1111 (2006).
15. A. H. Schinkel, U. Mayer, E. Wagenaar, C. A. Mol, L. van Deemter, J. J. Smit, M. A. van der Valk, A. C. Voordouw, H. Spits, O. van Tellingen, J. M. Zijlmans, W. E. Fibbe, and P. Borst. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 94:4028-4033 (1997).
16. R. W. Johnstone, A. A. Ruefli, and M. J. Smyth. Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem. Sci. 25:1-6 (2000).
17. J. Wijnholds, R. Evers, M. R. van Leusden, C. A. Mol, G. J. Zaman, U. Mayer, J. H. Beijnen, M. van der Valk, P. Krimpenfort, and P. Borst. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275-1279 (1997).
18. U. B. Kompella, K. J. Kim, and V. H. L. Lee. Active chloride transport in the pigmented rabbit conjunctiva. Curr. Eye Res. 12:1041-1048 (1993).
19. J. J. Yang, K.-J. Kim, and V. H. L. Lee. Role of P-Glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm. Res. 17:533-538 (2000).
20. J. J. Yang, H. Ueda, K.-J. Kim, and V. H. L. Lee. Meeting future challenges in topical ocular drug delivery: development of an air-interfaced primary culture of rabbit conjunctival epithelial cells on a permeable support for drug transport studies. J. Control Release 65:1-11 (2000).
21. M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254 (1976).
22. D. Keppler, I. Leier, G. Jedlitschky, and J. Konig. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. Chem. Biol. Interact. 111-112:153-161 (1998).
23. H. Huai-Yun, D. T. Secrest, K. S. Mark, D. Carney, C. Brandquist, W. F. Elmquist, and D. W. Miller. Expression of multidrug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem. Biophys. Res. Commun. 243:816-820 (1998).
24. M. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427 (1993).
25. J. V. Aukunuru, G. Sunkara, N. Bandi, W. B. Thoreson, and U. B. Kompella. Expression of multidrug resistance-associated protein (MRP) in human retinal pigmented epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm. Res. 18:565-572 (2001).
26. X. Decleves, A. Regina, J. Laplanche, F. Roux, B. Boval, J. Launay, and J. Scherrmann. Functional expression of P-glycoprotein and multidrug resistance-associated protein (mrp1) in primary cultures of rat astrocytes. J. Neurosci. Res. 60:594-601 (2000).
27. C. P. Duffy, C. J. Elliott, R. A. O'Connor, M. M. Heenan, S. Coyle, I. M. Cleary, K. Kavanagh, S. Verhaegen, C. M. O'Loughlin, R. NicAmhlaoibh, and M. Clynes. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur. J. Cancer 34:1250-1259 (1998).
28. K. Terashi, M. Oka, H. Soda, M. Fukuda, S. Kawabata, K. Nakatomi, K. Shiozawa, T. Nakamura, K. Tsukamoto, Y. Noguchi, M. Suenaga, C. Tei, and S. Kohno. Interactions of ofloxacin and erythromycin with the multidrug resistance protein (MRP) in MRP-overexpressing human leukemia cells. Antimicrob. Agents Chemother. 44:1697-1700 (2000).
29. R. Kannan, Y. Bao, Y. Wang, V. P. Sarthy, and N. Kaplowitz. Protection from oxidant injury by sodium-dependent GSH uptake in retinal Muller cells. Exp. Eye Res. 68:609-616 (1999).
30. N. Feller, H. J. Broxterman, D. C. Wahrer, and H. M. Pinedo. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett. 368:385-388 (1995).
31. Y. Chuman, Z. S. Chen, K. Seto, T. Sumizawa, T. Furukawa, A. Tani, M. Haraguchi, K. Niwa, K. Yamada, T. Aikou, and S. Akiyama. Reversal of MRP-mediated vincristine resistance in KB cells by buthionine sulfoximine in combination with PAK-104P. Cancer Lett. 129:69-76 (1998).
32. K. Ikeda, M. Oka, Y. Yamada, H. Soda, M. Fukuda, A. Kinoshita, K. Tsukamoto, Y. Noguchi, H. Isomoto, F. Takeshima, K. Murase, S. Kamihira, M. Tomonaga, and S. Kohno. Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. Int. J. Cancer 82:599-604 (1999).
33. H. S. Ginsberg, L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. U. S. A. 88:1651-1655 (1991).
34. J. J. Yang, D. Stevenson, M. D. Trousdale, and V. H. L. Lee. Interaction of adenovirus with conjunctival epithelial cells as a prelude to gene therapy. Proc. Int. Symp. Control. Released Bioact. Mater. 25:338-339 (1998).
35. D. A. Gamache, S. D. Dimitrijevich, L. K. Weimer, L. S. Lang, J. M. Spellman, G. Graff, and J. M. Yanni. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul. Immunol. Inflamm. 5:117-128 (1997).
36. S. Becker, H. S. Koren, and D. C. Henke. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am. J. Respir. Cell Mol. Biol. 8:20-27 (1993).
37. R. Arnold, B. Humbert, H. Werchau, H. Gallati, and W. Konig. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126-133 (1994).
38. D. W. McGee, S. J. Vitkus, and P. Lee. The effect of cytokine stimulation on IL-1 receptor mRNA expression by intestinal epithelial cells. Cell. Immunol. 168:276-280 (1996).
39. E. Uchio, S. Y. Ono, Z. Ikezawa, and S. Ohno. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin. Exp. Allergy 30:103-109 (2000).
40. K. Tsubota, K. Fukagawa, T. Fujihara, S. Shimmura, I. Saito, K. Saito, and T. Takeuchi. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest. Ophthalmol. Vis. Sci. 40:28-34 (1999).
41. U. Stein, W. Walther, C. M. Laurencot, G. L. Scheffer, R. J. Scheper, and R. H. Shoemaker. Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. J. Natl. Cancer Inst. 89:807-813 (1997).
42. O. L. Miakotina, M. Agassandian, L. Shi, D. C. Look, and R. K. Mallampalli. Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L93-L102 (2005).
43. A. T. Nies and D. Keppler. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 453: 643-659 (2006).
44. Q. C. Xia, J. J. Yang, and L. Gan. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions. Expert Opin. Drug Metab. Toxicol. 1:596-611 (2005).